You are here
VUBToday: Vaccination with tumour cells: opening up new options for cancer patients
Dendritic cells (DCs) are cells which activate our immune system. Until now the idea was that tumours block our defensive mechanism (against cancer) by supressing these dendritic cells. Professor Jo Van Ginderachter (VIB-Vrije Universiteit Brussel (VUB)) and his team have now shown a different light on the matter. The team discovered two types of DCs which appear in tumours and which activate the immune system. The scientists even managed to use them as a kind of vaccine to limit tumour growth. This study opens up new ways for innovative immunotherapies and was published in Nature Communications.